{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:59:29Z","timestamp":1787237969370,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00277-024-06151-7","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T20:43:21Z","timestamp":1737578601000},"page":"2387-2402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["How to combine multiple tools for the genetic diagnosis work-up of pediatric B-cell acute lymphoblastic leukemia\u00a0"],"prefix":"10.1007","volume":"104","author":[{"given":"Gloria","family":"Hidalgo-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara","family":"Taz\u00f3n-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Palacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Saumell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Mart\u00ednez-Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Murciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"D\u00edaz de Heredia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Armengol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"6151_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. https:\/\/doi.org\/10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"6151_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/HS9.0000000000000053","volume":"2","author":"C Schwab","year":"2018","unstructured":"Schwab C, Harrison CJ (2018) Advances in B-cell precursor acute lymphoblastic leukemia genomics. Hemasphere 2:1\u20139. https:\/\/doi.org\/10.1097\/HS9.0000000000000053","journal-title":"Hemasphere"},{"key":"6151_CR3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3324\/haematol.2018.204974","volume":"104","author":"M Zaliova","year":"2019","unstructured":"Zaliova M, Stuchly J, Winkowska L et al (2019) Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort. Haematologica 104:1396\u20131406. https:\/\/doi.org\/10.3324\/haematol.2018.204974","journal-title":"Haematologica"},{"key":"6151_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","volume":"51","author":"Z Gu","year":"2019","unstructured":"Gu Z, Churchman ML, Roberts KG et al (2019) PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet 51:296\u2013307. https:\/\/doi.org\/10.1038\/s41588-018-0315-5","journal-title":"Nat Genet"},{"key":"6151_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/bjh.17869","volume":"196","author":"CJ Schwab","year":"2022","unstructured":"Schwab CJ, Murdy D, Butler E et al (2022) Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification. Br J Haematol 196:753\u2013763. https:\/\/doi.org\/10.1111\/bjh.17869","journal-title":"Br J Haematol"},{"key":"6151_CR6","doi-asserted-by":"publisher","first-page":"E11711","DOI":"10.1073\/pnas.1814397115","volume":"115","author":"JF Li","year":"2018","unstructured":"Li JF, Dai YT, Lilljebj\u00f6rn H et al (2018) Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Proc Natl Acad Sci U S A 115:E11711\u2013E11720. https:\/\/doi.org\/10.1073\/pnas.1814397115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6151_CR7","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1182\/blood.2022015853","volume":"140","author":"EJ Duncavage","year":"2022","unstructured":"Duncavage EJ, Bagg A, Hasserjian RP et al (2022) Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia. Blood 140:2228\u20132247. https:\/\/doi.org\/10.1182\/blood.2022015853","journal-title":"Blood"},{"key":"6151_CR8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/ajh.26487","volume":"97","author":"K Rack","year":"2022","unstructured":"Rack K, De Bie J, Ameye G et al (2022) Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping. Am J Hematol 97:548\u2013561. https:\/\/doi.org\/10.1002\/ajh.26487","journal-title":"Am J Hematol"},{"key":"6151_CR9","unstructured":"Badell I, D\u00edaz de Heredia C, Dapena JL et al (2014) Recomendaciones terap\u00e9uticas LAL\/SEHOP-PETHEMA 2013"},{"key":"6151_CR10","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1080\/10428194.2021.1907375","volume":"62","author":"G Hidalgo-G\u00f3mez","year":"2021","unstructured":"Hidalgo-G\u00f3mez G, Palacio-Garcia C, Gallur L et al (2021) Is acute lymphoblastic leukemia with mature B-cell phenotype and KMT2A rearrangements a new entity? A systematic review and meta-analysis. Leuk Lymphoma 62:2202\u20132210. https:\/\/doi.org\/10.1080\/10428194.2021.1907375","journal-title":"Leuk Lymphoma"},{"key":"6151_CR11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3324\/haematol.2018.204487","volume":"104","author":"M Zaliova","year":"2019","unstructured":"Zaliova M, Potuckova E, Hovorkova L et al (2019) ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity. Haematologica 104:1407\u20131416. https:\/\/doi.org\/10.3324\/haematol.2018.204487","journal-title":"Haematologica"},{"key":"6151_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12102815","volume":"12","author":"JA Rehn","year":"2020","unstructured":"Rehn JA, O\u2019connor MJ, White DL, Yeung DT (2020) DUX hunting\u2014clinical features and diagnostic challenges associated with DUX4-rearranged leukaemia. Cancers (Basel) 12:1\u201315","journal-title":"Cancers (Basel)"},{"key":"6151_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/bloodadvances.2018025718","volume":"3","author":"L Hamadeh","year":"2019","unstructured":"Hamadeh L, Enshaei A, Schwab C et al (2019) Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL. Blood Adv 3:148\u2013157. https:\/\/doi.org\/10.1182\/bloodadvances.2018025718","journal-title":"Blood Adv"},{"key":"6151_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1200\/JCO","volume":"36","author":"M Qian","year":"2018","unstructured":"Qian M, Cao X, Devidas M et al (2018) TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children. J Clin Oncol 36:591\u2013599. https:\/\/doi.org\/10.1200\/JCO","journal-title":"J Clin Oncol"},{"key":"6151_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41375-022-01799-4","volume":"37","author":"C Schwab","year":"2023","unstructured":"Schwab C, Cranston RE, Ryan SL et al (2023) Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial. Leukemia 37:529\u2013538. https:\/\/doi.org\/10.1038\/s41375-022-01799-4","journal-title":"Leukemia"},{"key":"6151_CR16","doi-asserted-by":"publisher","first-page":"103434","DOI":"10.1016\/j.retram.2023.103434","volume":"71","author":"G Tueur","year":"2023","unstructured":"Tueur G, Quessada J, De Bie J et al (2023) Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH). Curr Res Transl Med 71:103434. https:\/\/doi.org\/10.1016\/j.retram.2023.103434","journal-title":"Curr Res Transl Med"},{"key":"6151_CR17","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.3390\/jcm","volume":"10","author":"I Iacobucci","year":"2021","unstructured":"Iacobucci I, Kimura S, Mullighan CG (2021) Clinical Medicine Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia. J Clin Med 10:3792. https:\/\/doi.org\/10.3390\/jcm","journal-title":"J Clin Med"},{"key":"6151_CR18","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","volume":"105","author":"H Inaba","year":"2020","unstructured":"Inaba H, Mullighan CG (2020) Pediatric acute lymphoblastic leukemia. Haematologica 105:2524\u20132539","journal-title":"Haematologica"},{"key":"6151_CR19","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","volume":"54","author":"SW Brady","year":"2022","unstructured":"Brady SW, Roberts KG, Gu Z et al (2022) The genomic landscape of pediatric acute lymphoblastic leukemia. Nat Genet 54:1376\u20131389. https:\/\/doi.org\/10.1038\/s41588-022-01159-z","journal-title":"Nat Genet"},{"key":"6151_CR20","doi-asserted-by":"publisher","unstructured":"Song Y, Fang Q, Mi Y (2022) Prognostic significance of copy number variation in B-cell acute lymphoblastic leukemia. Front Oncol 12. https:\/\/doi.org\/10.3389\/fonc.2022.981036","DOI":"10.3389\/fonc.2022.981036"},{"key":"6151_CR21","doi-asserted-by":"publisher","unstructured":"Steeghs EMP, Boer JM, Hoogkamer AQ et al (2019) Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia. Sci Rep 9. https:\/\/doi.org\/10.1038\/s41598-019-41078-4","DOI":"10.1038\/s41598-019-41078-4"},{"key":"6151_CR22","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1200\/JCO.2011.34.8144","volume":"29","author":"J Hof","year":"2011","unstructured":"Hof J, Krentz S, Van Schewick C et al (2011) Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia. J Clin Oncol 29:3185\u20133193. https:\/\/doi.org\/10.1200\/JCO.2011.34.8144","journal-title":"J Clin Oncol"},{"key":"6151_CR23","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1182\/blood-2019-01-852392","volume":"133","author":"CL Dieck","year":"2019","unstructured":"Dieck CL, Ferrando A (2019) Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL. Blood 133:2263\u20132268. https:\/\/doi.org\/10.1182\/blood-2019-01-852392","journal-title":"Blood"},{"key":"6151_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41375-021-01448-2","volume":"36","author":"AV Moorman","year":"2022","unstructured":"Moorman AV, Barretta E, Butler ER et al (2022) Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study. Leukemia 36:625\u2013636. https:\/\/doi.org\/10.1038\/s41375-021-01448-2","journal-title":"Leukemia"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06151-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-06151-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06151-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T23:13:46Z","timestamp":1746400426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-06151-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6151"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-06151-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4952979\/v1","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided informed consent in accordance with protocols approved by Institutional Ethics Committee of Vall d\u2019Hebron University Hospital and in compliance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}